mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.57 |
0.0005 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0006 |